Preliminary observations on the pathogenesis of experimental bovine spongiform encephalopathy (BSE): an update.

PubWeight™: 2.05‹?› | Rank: Top 2%

🔗 View Article (PMID 9501384)

Published in Vet Rec on January 31, 1998

Authors

G A Wells1, S A Hawkins, R B Green, A R Austin, I Dexter, Y I Spencer, M J Chaplin, M J Stack, M Dawson

Author Affiliations

1: Veterinary Laboratories Agency, Central Veterinary Laboratory, New Haw, Addlestone, Surrey.

Articles citing this

Preclinical diagnosis of scrapie by immunohistochemistry of third eyelid lymphoid tissue. J Clin Microbiol (2000) 2.63

Bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease. BMJ (2001) 2.17

Rapid prion neuroinvasion following tongue infection. J Virol (2003) 2.06

Natural and experimental oral infection of nonhuman primates by bovine spongiform encephalopathy agents. Proc Natl Acad Sci U S A (1999) 1.80

Early spread of scrapie from the gastrointestinal tract to the central nervous system involves autonomic fibers of the splanchnic and vagus nerves. J Virol (2001) 1.73

The sclera, the prion, and the ophthalmologist. Br J Ophthalmol (2002) 1.72

Evidence of scrapie transmission via milk. BMC Vet Res (2008) 1.68

Epidemiological determinants of the pattern and magnitude of the vCJD epidemic in Great Britain. Proc Biol Sci (1998) 1.64

Prions in skeletal muscle. Proc Natl Acad Sci U S A (2002) 1.48

Sheep and goat BSE propagate more efficiently than cattle BSE in human PrP transgenic mice. PLoS Pathog (2011) 1.38

Updated projections of future vCJD deaths in the UK. BMC Infect Dis (2003) 1.33

Prion infection of skeletal muscle cells and papillae in the tongue. J Virol (2004) 1.29

Bovine spongiform encephalopathy infectivity in greater kudu (Tragelaphus strepsiceros). Emerg Infect Dis (2004) 1.29

Retrograde transport of transmissible mink encephalopathy within descending motor tracts. J Virol (2002) 1.28

Estimation of the basic reproduction number of BSE: the intensity of transmission in British cattle. Proc Biol Sci (1999) 1.25

Extraneural prion neuroinvasion without lymphoreticular system infection. J Virol (2005) 1.22

Prion infection of oral and nasal mucosa. J Virol (2006) 1.20

Variant Creutzfeldt-Jakob disease: a summary of current scientific knowledge in relation to public health. CMAJ (2001) 1.18

Factors determining the pattern of the variant Creutzfeldt-Jakob disease (vCJD) epidemic in the UK. Proc Biol Sci (2003) 1.14

Pathogenesis of bovine spongiform encephalopathy in sheep. Arch Virol (2007) 1.14

A clinical study of kuru patients with long incubation periods at the end of the epidemic in Papua New Guinea. Philos Trans R Soc Lond B Biol Sci (2008) 1.10

Faecal shedding, alimentary clearance and intestinal spread of prions in hamsters fed with scrapie. Vet Res (2008) 1.05

Detection of prions in the faeces of sheep naturally infected with classical scrapie. Vet Res (2011) 0.96

Biochemical typing of pathological prion protein in aging cattle with BSE. Virol J (2009) 0.94

Assessment of the prevalence of vCJD through testing tonsils and appendices for abnormal prion protein. Proc Biol Sci (2000) 0.93

Evaluation of Western blotting methods using samples with or without sodium phosphotungstic acid precipitation for diagnosis of scrapie and chronic wasting disease. Can J Vet Res (2005) 0.91

Experimental oral transmission of chronic wasting disease to red deer (Cervus elaphus elaphus): early detection and late stage distribution of protease-resistant prion protein. Can Vet J (2010) 0.90

Quantifying the risk from ovine BSE and the impact of control strategies. Proc Biol Sci (2007) 0.90

Involvement of the peripheral nervous system in human prion diseases including dural graft associated Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry (2005) 0.84

Relationship between clinical signs and postmortem test status in cattle experimentally infected with the bovine spongiform encephalopathy agent. BMC Vet Res (2010) 0.83

Neuroinvasion in prion diseases: the roles of ascending neural infection and blood dissemination. Interdiscip Perspect Infect Dis (2010) 0.83

Enhanced virulence of sheep-passaged bovine spongiform encephalopathy agent is revealed by decreased polymorphism barriers in prion protein conversion studies. J Virol (2013) 0.82

Accelerated, spleen-based titration of variant Creutzfeldt-Jakob disease infectivity in transgenic mice expressing human prion protein with sensitivity comparable to that of survival time bioassay. J Virol (2014) 0.81

Prions and dentistry. J R Soc Med (2002) 0.80

Population-level retrospective study of neurologically expressed disorders in ruminants before the onset of bovine spongiform encephalopathy (BSE) in Belgium, a BSE risk III country. J Clin Microbiol (2005) 0.79

Pathogenesis of experimental bovine spongiform encephalopathy (BSE): estimation of tissue infectivity according to incubation period. Vet Res (2008) 0.78

Morphometric comparison of the lumbar cancellous bone of sheep, deer, and humans. Comp Med (2010) 0.78

Minimum Effective Dose of Cattle and Sheep BSE for Oral Sheep Infection. PLoS One (2016) 0.77

Complementary studies detecting classical bovine spongiform encephalopathy infectivity in jejunum, ileum and ileocaecal junction in incubating cattle. Vet Res (2013) 0.75

Transmission of sheep-bovine spongiform encephalopathy to pigs. Vet Res (2016) 0.75

Disease-associated prion protein in neural and lymphoid tissues of mink (Mustela vison) inoculated with transmissible mink encephalopathy. J Comp Pathol (2012) 0.75

BSE safety standards: An evaluation of public health policies of Japan, Europe, and USA. Environ Health Prev Med (2005) 0.75

Articles by these authors

Transmission dynamics and epidemiology of BSE in British cattle. Nature (1996) 6.15

A novel progressive spongiform encephalopathy in cattle. Vet Rec (1987) 4.39

Primary parenteral transmission of bovine spongiform encephalopathy to the pig. Vet Rec (1990) 2.19

Scrapie surveillance in Great Britain: results of an abattoir survey, 1997/98. Vet Rec (2000) 2.17

Detection of herpes simplex virus mRNA in latently infected trigeminal ganglion neurons by in situ hybridization. Ann Neurol (1982) 2.12

First case of H-type bovine spongiform encephalopathy identified in Great Britain. Vet Rec (2007) 2.08

Towards a differential polymerase chain reaction test for Chlamydia psittaci. Vet Rec (1991) 1.94

Different forms of the bovine PrP gene have five or six copies of a short, G-C-rich element within the protein-coding exon. J Gen Virol (1991) 1.88

Markedly increased susceptibility to natural sheep scrapie of transgenic mice expressing ovine prp. J Virol (2001) 1.86

Molecular screening of sheep for bovine spongiform encephalopathy. Neurosci Lett (1998) 1.74

An epidemiologic study of multiple sclerosis in Northern Ireland. Neurology (1998) 1.72

Structural features of the colony-stimulating factor 1 receptor that affect its association with phosphatidylinositol 3-kinase. EMBO J (1990) 1.72

New variant Creutzfeldt-Jakob disease: neurological features and diagnostic tests. Lancet (1997) 1.70

Translational regulation: identification of the site on bacteriophage T4 rIIB mRNA recognized by the regA gene function. Proc Natl Acad Sci U S A (1981) 1.63

Cognitive mechanisms, specificity and neural underpinnings of visuospatial peaks in autism. Brain (2006) 1.62

Oral inoculation of sheep with the agent of bovine spongiform encephalopathy (BSE). 1. Onset and distribution of disease-specific PrP accumulation in brain and viscera. J Comp Pathol (2001) 1.60

Electrophoretic separation and molecular weight characterization of Pseudomonas aeruginosa H-antigen flagellins. Infect Immun (1985) 1.55

Fibrils from brains of cows with new cattle disease contain scrapie-associated protein. Nature (1988) 1.54

Effect of sequence variation in meningococcal PorA outer membrane protein on the effectiveness of a hexavalent PorA outer membrane vesicle vaccine. Vaccine (2000) 1.51

Preliminary findings on the experimental transmission of chronic wasting disease agent of mule deer to cattle. J Vet Diagn Invest (2001) 1.46

Influence of CCR5 delta32 polymorphism on multiple sclerosis susceptibility and disease course. Mult Scler (2004) 1.45

Routine application of enzyme-linked immunosorbent assay in comparison with complement fixation for the diagnosis of foot-and-mouth and swine vesicular diseases. Vet Microbiol (1988) 1.43

An evaluation of interleukin genes fails to identify clear susceptibility loci for multiple sclerosis. J Neurol Sci (2000) 1.40

Travel sickness in pigs and sheep. Vet Rec (1996) 1.39

Unsuccessful oral transmission of scrapie from British sheep to cattle. Vet Rec (2013) 1.39

A methodology based on NMR spectroscopy for the forensic analysis of condoms. J Forensic Sci (2001) 1.38

Three-dimensional imaging of magnetic domains. Nat Commun (2010) 1.38

Detection of disease-specific PrP in the distal ileum of cattle exposed orally to the agent of bovine spongiform encephalopathy. Vet Rec (2003) 1.37

Overexpression of eukaryotic initiation factor 4E (eIF4E) in breast carcinoma. Cancer (1997) 1.33

Translational repression: biological activity of plasmid-encoded bacteriophage T4 RegA protein. J Mol Biol (1987) 1.26

Design and utility of oligonucleotide gene probes for fungal polyketide synthases. Chem Biol (2001) 1.22

Novel polymorphisms in the caprine PrP gene: a codon 142 mutation associated with scrapie incubation period. J Gen Virol (1996) 1.21

Asymmetry of gait initiation in hemiparetic stroke subjects. Arch Phys Med Rehabil (1997) 1.21

Postmortem diagnosis of preclinical and clinical scrapie in sheep by the detection of disease-associated PrP in their rectal mucosa. Vet Rec (2006) 1.21

The ribosomal intergenic spacer region: a target for the PCR based diagnosis of tuberculosis. Tuber Lung Dis (1994) 1.18

Infectivity in the ileum of cattle challenged orally with bovine spongiform encephalopathy. Vet Rec (1994) 1.18

Hydrated autoclave pretreatment enhancement of prion protein immunoreactivity in formalin-fixed bovine spongiform encephalopathy-affected brain. Acta Neuropathol (1994) 1.17

Pathogenicity of a swine influenza H1N1 virus antigenically distinguishable from classical and European strains. Vet Rec (1993) 1.14

Immunopurification of functional Asp-ase (natural killer cell granzyme B) using a monoclonal antibody. Biochem Biophys Res Commun (1993) 1.14

Tissue distribution of bovine spongiform encephalopathy infectivity in Romney sheep up to the onset of clinical disease after oral challenge. Vet Rec (2005) 1.13

Identification of two new bacteriophage T4 genes that may have roles in transcription and DNA replication. J Virol (1987) 1.11

Bovine spongiform encephalopathy: the effect of oral exposure dose on attack rate and incubation period in cattle. J Gen Virol (2007) 1.10

Genetic analysis of capsular status of meningococcal carrier isolates. Epidemiol Infect (2003) 1.09

Global survey of serological evidence of caprine arthritis-encephalitis virus infection. Vet Rec (1984) 1.07

Immunohistochemical detection of PrP in the medulla oblongata of sheep: the spectrum of staining in normal and scrapie-affected sheep. Vet Rec (2001) 1.06

A double-blind controlled trial of long chain n-3 polyunsaturated fatty acids in the treatment of multiple sclerosis. J Neurol Neurosurg Psychiatry (1989) 1.06

Relationships between chemical changes and histological damage in the brains of scrapie affected mice. J Comp Pathol (1967) 1.05

Traumatic Brown-Séquard-plus syndrome. Arch Neurol (2001) 1.05

Frequencies of PrP genotypes in 38 breeds of sheep sampled in the National Scrapie Plan for Great Britain. Vet Rec (2005) 1.05

Transmission of bovine spongiform encephalopathy to mice. Vet Rec (1988) 1.05

BSE immunohistochemical patterns in the brainstem: a comparison between UK and Italian cases. Acta Neuropathol (2006) 1.01

Antigenic and morphological differentiation of placental and intestinal isolates of Chlamydia psittaci of ovine origin. Vet Microbiol (1992) 1.01

Comparison of serological tests used in three state veterinary laboratories to identify maedi-visna virus infection. Vet Rec (1982) 1.01

Relationship between physiological loss, performance decrement, and age in master athletes. J Gerontol A Biol Sci Med Sci (2001) 1.00

Umbilical cord circumference at birth. Am J Dis Child (1989) 1.00

Serum neurone-specific enolase as an indicator of stroke volume. Eur J Clin Invest (1996) 0.99

Retinoid-resistant estrogen receptor-negative human breast carcinoma cells transfected with retinoic acid receptor-alpha acquire sensitivity to growth inhibition by retinoids. J Biol Chem (1994) 0.99

Viral antibody titers. Comparison in patients with multiple sclerosis and rheumatoid arthritis. Arch Neurol (1987) 0.98

Behavior analysis in consumer affairs: Retail and consumer response to publicizing food price information. J Appl Behav Anal (1984) 0.98

Maedi/visna: a review. Vet Rec (1980) 0.97

Immunoperoxidase detection of chlamydia ovis in experimentally-infected cell culture. Br Vet J (1981) 0.97

RS-127445: a selective, high affinity, orally bioavailable 5-HT2B receptor antagonist. Br J Pharmacol (1999) 0.97

Genetic mapping of the amino-terminal domain of bacteriophage T4 DNA polymerase. Genetics (1987) 0.97

Improved expression of human interleukin-2 in high-cell-density fermentor cultures of Escherichia coli K-12 by a phosphotransacetylase mutant. Appl Environ Microbiol (1990) 0.97

Clinical study of primary progressive multiple sclerosis in Northern Ireland, UK. J Neurol Neurosurg Psychiatry (1998) 0.96

Rapid test for the preclinical postmortem diagnosis of BSE in central nervous system tissue. Vet Rec (2001) 0.96

Mutation testing in Treacher Collins Syndrome. J Orthod (2002) 0.96

Pathogenesis of maedi-visna. Vet Rec (1987) 0.96

Evaluation of zinc salt based fixatives for preserving antigenic determinants for immunohistochemical demonstration of murine immune system cell markers. Biotech Histochem (2006) 0.96

Factors affecting the frequency infection in renal transplant recipients. Arch Intern Med (1976) 0.96

Granule serine proteases are normal nuclear constituents of natural killer cells. J Biol Chem (1994) 0.95

An assessment of the spectrum of disability and handicap in multiple sclerosis: a population-based study. Mult Scler (2001) 0.95

Estimating the temporal relationship between PrPSc detection and incubation period in experimental bovine spongiform encephalopathy of cattle. J Gen Virol (2007) 0.93

Multiple cases of maedi and visna in a flock in East Anglia. Vet Rec (1995) 0.93

Use of computerized neuropsychological tests (CANTAB) to assess cognitive effects of antihypertensive drugs in the elderly. Cambridge Neuropsychological Test Automated Battery. J Hypertens (1999) 0.93

Bovine spongiform encephalopathy: investigation of phenotypic variation among passive surveillance cases. J Comp Pathol (2010) 0.93

4-Amino-3-(3'-methoxycarbonyl-2'-thioureido)benzophenone, a prodrug of mebendazole. Eur J Drug Metab Pharmacokinet (1984) 0.93

Serum neurone specific enolase (NSE) levels as an indicator of neuronal damage in patients with cerebral infarction. Eur J Clin Invest (1991) 0.93

Novel properties of the protein kinase CK2-site-regulated nuclear- localization sequence of the interferon-induced nuclear factor IFI 16. Biochem J (2001) 0.93

Evaluation of the effects of controlled autolysis on the immunodetection of PrP(Sc) by immunoblotting and immunohistochemistry from natural cases of scrapie and BSE. Res Vet Sci (2002) 0.92

Cytochrome P450105D1 (CYP105D1) from Streptomyces griseus: heterologous expression, activity, and activation effects of multiple xenobiotics. Biochem Biophys Res Commun (1999) 0.92

Maximal aerobic power, lactate threshold, and running performance in master athletes. Med Sci Sports Exerc (2000) 0.91

Spastic syndrome in a Holstein bull: a histologic study. Vet Pathol (1987) 0.91

Expression of the bilateral deficit during reflexively evoked contractions. J Appl Physiol (1985) (2002) 0.91

The demonstration of maedi/visna virus in sheep in Great Britain. Vet Rec (1979) 0.90

Diagnosis of preclinical and subclinical scrapie in a naturally infected sheep flock utilizing currently available postmortem diagnostic techniques. J Vet Diagn Invest (2001) 0.90

Subsets of T lymphocytes in relation to T lymphocyte function in multiple sclerosis. Clin Exp Immunol (1985) 0.90